Primary hyperparathyroidism in neonates and childhood: The French experience (1984-2004)

Hormone Research

Volumn 69, Issue 3, 2008, Pages 180-188

  Mallet, Eric ^a   Amrein, ^b   Bertrand, ^b   Bost, ^b   Chaussain, ^b   David, ^b   Delaporte, ^b   Despert, ^b   Fekete, ^b   Garabedian, ^b   Guerin ^b   Guillot, ^b   Lenoir, ^b   Lienhardt, ^b   Limal, ^b   Loirat, ^b   Loeuille, ^b   Nicolino, ^b   Polak, ^b   Simonin, ^b   Soskin, ^b   Thieuleux, ^b   Tricoire, ^b   Wagner, ^b   Ythier, ^b   more..

^a HÔPITAL CHARLES NICOLLE   (France)

^b NONE

Author keywords

Calcium sensing receptor; Children, primary hyperparathyroidism in; Hyperparathyroidism, primary; Multiple endocrine neoplasia; Neonates, primary hyperparathyroidism in

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CALCIUM SENSING RECEPTOR; CORTICOSTEROID; DIURETIC AGENT; ETIDRONIC ACID; FUROSEMIDE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PAMIDRONIC ACID; PARATHYROID HORMONE; THALLIUM; VITAMIN D;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD; ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE NEOPLASIA; NEWBORN; PARATHYROID ADENOMA; PARATHYROIDECTOMY; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; SCINTIGRAPHY;

ADENOMA; ADOLESCENT; AGE DISTRIBUTION; CALCIUM; CHILD; CHILD, PRESCHOOL; FEMALE; FRANCE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; INFANT; INFANT, NEWBORN; MALE; MULTIPLE ENDOCRINE NEOPLASIA; MUTATION; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; PHOSPHATES; RECEPTORS, CALCIUM-SENSING; RETROSPECTIVE STUDIES;

EID: 38549095687     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112592     Document Type: Article

References (25)

1. Hsu SC, Levine MA: Primary hyperparathyroidism in children and adolescents: the Johns Hopkins Children's Center Experience 1984-2001. J Bone Miner Res 2002;17:44-50.
2. Harman CR, Van Heerden JA, Farley DR, Grant CS, Thompson GB, Curlee K: Sporadic primary hyperparathyroidism in young patients. A separate disease entity? Arch Surg 1999;134:651-656.
3. Kollars J, Zarroug AE, Van Heerden J, Lteif A, Stavlo P, Suarez L, Moir C, et al: Primary hyperparathyroidism in pediatric patients. Pediatrics 2005;115:1073.
4. Pearce SH, Trump D, Wooding C, Besser GM, Chew SL, Grant DB, Heath DA, Hugues A, Paterson CR, Whyte MP, Thakker RV: Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest 1995;96:2683-2692.
5. Waller S, Kurzawinski T, Splitz L, Thakker R, Cranston T, Pearce S, Cheetham T, Van't Hoff WG: Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy. Eur J Pediatr 2004;163:589-594.
6. Ward BK, Magno AL, David EA, Hanyaloglu AC, Stuckey BG, Burrows M, Eidne KA, et al: Functional deletion of the calcium-sensing receptor in a case of neonatal severe hyperparathyroidism. J Clin Endocrinol Metab 2004;89:3721-3730.
7. Rodriguez Cueto G, Manzana Sierra C, Villalpando-Hernandez S: Preoperative ultrasonographic diagnosis of parathyroid adenoma in a child. Pediatr Radiol 1984;4:47-48.
8. Jones JM, Russel CF, Fergusson WR, Laird JD: Pre-operative sestamibi-technetium substraction scintigraphy in primary hyperparathyroidism: experience with 156 consecutives patients. Clin Radiol 2001;56:556-559.
9. Blanco I, Carril JM, Banzo I, Quirce R, Guttierez C, Uriarte I, Montero A, Vallina NK: Double-phase Tc-99m sestamibi scintigraphy in the preoperative location of lesions causing hyperparathyroidism. Clin Nucl Med 1998;23:291-297.
10. De Feo ML, Colagrande S, Biagini C, Tonarelli A, Bisi G, Vagelli L, Borrelli D, Cicchi P, Tonelli F, Amorosi A, Serio M, Brandi ML: Parathyroid glands: combination of 99mTc MIBI Scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology 2000;214:393-402.
11. Berczi C, Mezosi E, Galuska L, Varga J, Bajnok L, Lukas G, Balazs G: Technetium-99m-sestamibi/pertechnate substraction scintigraphy vs. ultrasonography for preoperative localization in primary hyperparathyroidism. Eur Radiol 2002;12:605-609.
12. Meola M, Barsotti M, Lenti C, Luperini M, Cavanna L, Barsotti G: Color-Doppler in the imaging work-up of primary hyperparathyroidism. J Nephrol 1999;12:270-274.
13. Purcell GP, Dirbas FM, Jeffrey RB, Lane MJ, Desser T, McDougall IR, Weigel RJ: Parathyroid localization with high-resolution ultrasound and technetium Tc99m sestamibi. Arch Surg 1999;134:824-830.
14. Solorzano CC, Lee TM, Ramirez MC, Carneiro DM, Irvin GL: Surgeon-performed ultrasound improves localization of abnormal parathyroid glands. Am Surg 2005;71:557-562.
15. Shen W, Sabanci U, Morita ET, Siperstein AE, Duh QY, Clark OH: Sestamibi scanning in adequate for directing unilateral neck exploration fort first-time parathyroidectomy. Arch Surg 1997;132:969-976.
16. Mariani G, Gulec SA, Rubello D, Boni G, Puccini M, Pelizzo MR, Manca G, Casara D, Sotti G, Erba P, Volterrani D, Giuliano AE: Preoperative localization and radioguided parathyroid surgery. J Nucl Med 2003;44:1443-1458.
17. Adda G, Scillitani A, Epaminondas P, Di Lembo S, Motta F, Cecconi P, Vecchi G, Arosio M, Chiodini I: Ultrasound guided laser thermal ablation for parathyroid adenomas: analysis of three cases with a three-year following up. Horm Res 2006;65:231-234.
18. Nussbaum SR, Thompson AR, Hutcheson KA, Gaz RD, Wang CA: Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism. Surgery 1988;104:1121-1127.
19. Mandell DL, Genden EM, Mechanik JI, Bergman DA, Diamond EJ, Urken ML: The influence of intraoperative parathyroid hormone monitoring on the surgical management of hyperparathyroidism. Arch Otolaryngol Head Neck Surg 2001;127:821-827.
20. Grall Lerosey M, Mallet E, Chomant J, Basuyau JP, Dacher JN, Lechevallier J, Bachy B: Moyens actuels de localisation de l'adénome parathyroïdien chez l'enfant. Arch Pédiatr 1997;4:802-803.
21. Bergson EJ, Sznyter LA, Dubner S, Palestro CJ, Heller KS: Sestamibi scans and intraoperative parathyroid hormone measurement in the treatment of primary hyperparathyroidism. Arch Otolaryngol Head Neck Surg 2004;130:87-91.
22. Allgrove J: Use of biphosphonates in children and adolescents. J Pediatr Endocrinol Metab 2002;15(suppl 3):921-928.
23. Lawson ML, Miller SE, Ellis G, Filler RM, Kooh SW: Primary hyperparathyroidism in a paediatric hospital. QJM 1996;89:921-932.
24. Chesney RW: Primary hyperparathyroidism in pediatric patients: clearcut differences form adult patients. Pediatrics 2005;115:1073.
25. Mallet E, Basuyau JP: Intérêt du dosage de la PTH intacte dans les dysmétabolies calciques de l'enfant. Arch Fr Pédiatr 1988;45:597-599.